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-1,4-Galactanases are glycoside hydrolases that are involved in the degradation
of pectin and belong to family 53 in the classiﬁcation of glycoside hydrolases.
Previous studies have elucidated the structures of several fungal and two
bacterial galactanases, while biochemical studies have indicated differences in
the product proﬁles of different members of the family. Structural studies of
ligand complexes have to date been limited to the bacterial members of the
family. Here, the ﬁrst structure of a fungal galactanase in complex with a
disaccharide is presented. Galactobiose binds to subsites 1 and 2, thus
improving our understanding of ligand binding to galactanases.
1. Introduction
-1,4-Galactanases are glycoside hydrolases (EC 3.2.1.89) that
degrade galactan and arabinogalactan side chains of rhamno-
galacturonan I, the most studied and abundant component of
pectin found in non-woody plant cell walls (Lau et al., 1985).
The hydrolysis takes place by a double-displacement retaining
mechanism involving two carboxylic acid residues, one func-
tioning as a catalytic nucleophile and the other as a general
acid/base. Among other applications, galactanases can be used
as supplements for biomass degradation (de Lima et al., 2016).
According to the CAZY classiﬁcation, the enzymes are clas-
siﬁed into family GH53 (Lombard et al., 2014) in clan GH-A
(Jenkins et al., 1995; Davies & Henrissat, 1995). Structures of
-1,4-galactanases have been reported previously from
four fungi: Thermothelomyces thermophila (also known as
Myceliophthora thermophila; MtGal; GenBank ID
AAE73520.1; PDB entries 1hjs and 1hju; Le Nours et al.,
2003), Humicola insolens (HiGal; GenBank ID AAN99815.1;
PDB entry 1hjq; Le Nours et al., 2003), Aspergillus aculeatus
KSM 510 (AaGal; GenBank ID AAA32692.1; PDB entries
1fhl and 1fob; Ryttersgaard et al., 2002) and the closely related
A. nidulans FGSC A4 (EnGal; GenBank ID ABF50874.1;
PDB entry 4bf7; Otten et al., 2013). Additionally, a galactanase
from the soil bacterium Bacillus licheniformis has been
structurally characterized in complex with galactooligo-
saccharides (BlGal; GenBank ID AAO31370.1; PDB entries
1r8l, 1ur0, 1ur4, 2ccr, 2gft and 2j74; Ryttersgaard et al., 2004;
Le Nours et al., 2009), and very recently (during review of this
manuscript) the ﬁrst galactanase structure from a human gut
bacterium, Bacteroides thetaiotaomicron, has also been
determined (BtGH53; GenBank ID AAO79773.1; PDB
entries 6gp5 and 6gpa; Bo¨ger et al., 2019). Two of the struc-
turally characterized fungal enzymes are thermophilic, and the
available structures have also been used to design or ratio-
nalize thermostability mutants in two fungal enzymes (Larsen
et al., 2015; Torpenholt et al., 2015).
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A number of fungal and bacterial -1,4-galactanases have
also been characterized biochemically. From the studies
conducted so far, even though fungal galactanases attack the
internal glycosidic linkages in the polysaccharides and are thus
true endo enzymes, they eventually release shorter products
and can hydrolyse small substrates, both oligosaccharides and
small chromogenic substrates. As an example, AaGal and
Meripilus giganteus -1,4-galactanase are able to hydrolyse
both 2-nitrophenyl-1,4--d-galactopyranoside (with accom-
panying transglycosylation) and 4-nitrophenyl-1,4--d-thio-
galactobioside, while BlGal was completely inactive on these
substrates (Torpenholt et al., 2011). Even earlier work showed
that BlGal could not degrade galactotriose, while AaGal was
able to (Ryttersgaard et al., 2004). Another bacterial galac-
tanase from Geobacillus stearothermophilus produces mostly
galactotetraose from galactan, and was also shown not to
degrade galactotriose to smaller oligosaccharides (Tabach-
nikov & Shoham, 2013), while the galactanase from Biﬁdo-
bacterium longum was reported to produce galactotriose by a
processive mechanism (Hinz et al., 2005). However, in a more
recent study a bacterial galactanase from Bacteroides theta-
iotaomicron showed the ability to degrade potato galactan to
galactobiose (77%) and galactose (23%) (van Bueren et al.,
2017; Bo¨ger et al., 2019), thus showing that bacteria possess
galactanases with diverse degradation patterns. Structural
comparison suggests that the differences in product proﬁle
between the fungal and BlGal galactanases and the inability of
the latter to degrade galatotriose is owing to the fact that
BlGal has a more extended glycone substrate-binding site
and thus can bind small oligosaccharides nonproductively
(Ryttersgaard et al., 2004; Torpenholt et al., 2011). Although
crystallographic complexes with oligosaccharides have been
obtained with BlGal (Ryttersgaard et al., 2004; Le Nours et al.,
2009), no ligand complex of a fungal galactanase has been
reported in the literature to date.
2. Materials and methods
2.1. Macromolecule production
The cloning and expression of AaGal (GenBank ID
AAA32692.1) is described in detail in Dorreich et al. (1995).
Wild-type AaGal was puriﬁed from the cell extract (provided
by Novozymes A/S) in a similar way to that described in
Christgau et al. (1995). 300 mg of the cell extract was dissolved
in 9.5 ml 50 mM Tris pH 6.5, passed through a 0.22 mmMillex-
GV ﬁlter and puriﬁed on a Q Sepharose 16/10 column using a
gradient of 1M sodium chloride in 50 mM Tris pH 6.5. The
pooled fractions containing protein were reduced in volume
by centrifugation at 4500 rev min1 through an Amicon
Ultra-15 10 000 molecular-weight cutoff ﬁlter unit and ﬁltrated
through a 0.22 mm Ultrafree-MC ﬁlter. The purity was judged
by SDS–PAGE on polyacrylamide gels (4–20% from Bio-Rad
or 4–12% from NuPAGE) after heat denaturation in the
presence of DTT. The gels were stained with Instant Blue from
Expedeon. The enzyme was greater than 95% pure as judged
from the SDS–PAGE gel.
The puriﬁed protein was dialysed into 50 mM citrate pH 4.5
using a 10 000 molecular-weight cutoff Slide-A-Lyzer dialysis
cassette. The protein concentration was determined from
absorbance measurements at 280 nm using an NanoDrop 1000
spectrophotometer from Fisher Scientiﬁc, and the ﬁnal
concentration was determined to be 6.5 mg ml1. The protein
stock was further concentrated prior to crystallization.
2.2. Crystallization
Crystallization was carried out by hanging-drop vapour
diffusion at room temperature using a 24-well tray from
Hampton Research. During our structural studies of fungal
galactanases, ligand soaking of galactobiose, galactotriose and
modiﬁed carbohydrate analogues was attempted with several
enzymes and different crystallization conditions, initially with
little success. For AaGal, the original structure was deter-
mined at pH 7.5 in the presence of 0.2M calcium chloride and
PEG 400 as the main precipitant (Ryttersgaard et al., 1999).
As no carbohydrate ligand could be observed in crystals
grown close to these conditions and soaked with ligands, it was
hypothesized that the use of a pH far from the optimum for
this enzyme and/or the high concentration of calcium, which is
found bound near the enzyme active site in the native struc-
ture, could be interfering. Thus, a number of two-dimensional
screens were carried out inspired by the original crystallization
conditions, exploring PEGs of different molecular weights as
precipitants and using lower pH values and concentrations of
divalent metal ions than were used to obtain the native
structure.
The crystal that was utilized for the successful ligand
complex in this study was grown as follows: 1 ml AaGal stock
at 7.3 mg ml1 concentration in 50 mM acetate pH 4.0 was
mixed with 3 ml reservoir solution and equilibrated against
1.0 ml reservoir solution consisting of 0.1M calcium chloride,
0.1M sodium acetate pH 4.5, 30% PEG 3000 at room
temperature. Prior to soaking the crystal in a galactobiose-
containing solution, the pH in the drop was measured to be
4.2. The crystal was soaked for 1 min in 0.2M -1,4-galacto-
biose (Megazyme) in 30% PEG 3000 and was cryoprotected in
25% PEG 400 in reservoir solution before data collection.
2.3. Data collection and processing
Data were collected from a cryocooled crystal (100 K)
mounted in a cryoloop on beamline I911-2 at MAX-lab, Lund,
Sweden. The data set was obtained in 2011, and thus was
collected and processed rather conservatively with respect to
resolution limit. Processing was carried out with XDS and
XSCALE (Kabsch, 2010). Details of the data-processing
statistics are given in Table 1. Reprocessing using a current
version of XDS gives a CC1/2 of over 90% in the outer reso-
lution shell.
2.4. Structure solution and refinement
The structure was determined using the known structure of
AaGal obtained at pH 7.5 (100 K; PDB entry 1fob) as a search
model for molecular replacement. Molecular replacement was
research communications
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carried out using Phaser-MR in PHENIX (Adams et al., 2010).
The rotation-function Z scores for the two molecules were
15.7 and 16.7 and the translation-function Z scores were 50.3
and 88.1, with no clashes, with a ﬁnal log-likelihood gain of
4366. The structure was reﬁned using REFMAC5 in the CCP4
package (Winn et al., 2011) together with visual inspection
using Coot (Emsley et al., 2010). The ﬁnal model contained
galactobiose at the active site and a glycosylation at Asn112
modelled by two consecutive N-acetylglucosamines (NAG)
and a -mannose (BMA). Seven calcium ions were modelled
as well as some other ligands consisting of acetate and several
PEG fragments of different lengths from the crystallization/
cryoprotecting liquor. The glycosylation as well as the
galactobiose bound at the active site were validated in
Privateer (Agirre et al., 2015) and exhibited an acceptable level
of conﬁdence. The galactobiose displayed a real-space corre-
lation coefﬁcient (RSCC) value of greater than 0.90, while the
NAG constituents of the glycosylation exhibited values of at
least 0.89. However, the BMA constituents only gave values of
0.75 for chain A and 0.61 for chain B, which is most likely
owing to disorder. The reﬁnement statistics are summarized in
Table 2.
3. Results and discussion
The structure of AaGal in complex with galactobiose was
determined to a maximum resolution of 2.7 A˚ (Fig. 1). As a
member of the GH-A clan, the overall fold of the enzyme has
a (/)8-barrel architecture. The two catalytic glutamic acid
residues are located at the end of -strands 4 (acid/base,
Glu136) and 7 (nucleophile, Glu246), and the glycosylation
is positioned at Asn112. In a previously published AaGal
structure (PDB entry 1fob) a Ca2+ ion is present in the active
site. This is not observed in the current structure as galacto-
biose is able to compete with this particular position of the ion
under the new crystallization conditions. However, several
calcium ions are present in the structure. The space group was
I4122, with two molecules in the asymmetric unit. The
previously reported structures of AaGal (PDB entry 1fob at
100 K and PDB entry 1fhl at 293 K) belonged to space group
I222 with one molecule in the asymmetric unit (Ryttersgaard
et al., 2002). Both chain A and chain B superimpose well on
PDB entry 1fob, with root-mean-square deviations (r.m.s.d.s)
of 0.6 A˚ for all atoms and 0.4 A˚ for C atoms. Superimposition
of chainA on chain B gives r.m.s.d.s of 0.47 A˚ for all atoms and
0.19 A˚ for C atoms, which indicate that the two molecules in
the asymmetric unit are close to identical.
Galactobiose binding identiﬁed two subsites, 1 and 2,
deﬁned using the standard nomenclature (Davies et al., 1997)
with minus subsites towards the reducing end and plus subsites
towards the nonreducing end of the substrate. Hydrolysis
occurs between subsites 1 and +1.
3.1. Subsite 1
This subsite, which is occupied for the ﬁrst time in a GH53
crystal structure, is located near the catalytic active-site resi-
dues Glu136 and Glu246. O"1 and O"2 of both Glu136 and
Glu246 are within hydrogen-bonding distance of the O1 and
O2 hydroxyl groups, respectively, of the galactose unit.
Potential hydrogen bonds are also observed between O2 of
galactose and N2 of Asn135, and between O6 of galactose and
the backbone O atom of Leu307, the hydroxyl group of Tyr218
and a water molecule. O1 and O3 in the galactose unit are
hydrogen-bonded to water molecules. Trp297 serves as an
aromatic platform at the 1 subsite. The modelled galactose
research communications
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Table 2
Structure solution and reﬁnement.
Values in parentheses are for the outer shell.
Resolution range (A˚) 50.00–2.69 (2.76–2.69)
Completeness (%) 98.5 (94.4)
No. of reﬂections, working set 26963 (2013)
No. of reﬂections, test set 1517 (81)
Final Rcryst 0.145 (0.219)
Final Rfree 0.211 (0.289)
Cruickshank DPI 0.4008
No. of non-H atoms
Protein 5341
Ions 7
Other ligands 146
Water 222
Total 5716
R.m.s. deviations
Bonds (A˚) 0.0142
Angles () 1.7663
Average B factors (A˚2)
Protein, chain A 38.41
Protein, chain B 41.06
Galactobiose, chain A 44.05
Galactobiose, chain B 42.95
Glycosylation, chain A 56.97
Glycosylation, chain B 58.03
Ions 64.93
Other ligands 71.24
Water 35.41
Ramachandran plot†
Most favoured (%) 96.37
Allowed (%) 3.63
† The Ramachandran plot was generated using dynarama in Coot (Emsley et al., 2010).
Table 1
Data collection and processing.
Values in parentheses are for the outer shell.
Diffraction source I911-2, MAX-lab
Wavelength (A˚) 1.03973
Temperature (K) 100
Detector MAR 165 CCD
Crystal-to-detector distance (mm) 150
Rotation range per image () 1.0
Total rotation range () 200
Exposure time per image (s) 30
Space group I4122
a, b, c (A˚) 200.2, 200.2, 106.8
, ,  () 90, 90, 90
Mosaicity () 0.33
Resolution range (A˚) 50.0–2.69 (2.76–2.69)
Total No. of reﬂections 475968
No. of unique reﬂections 29998
Completeness (%) 98.5 (94.3)
Multiplicity 15.9 (12.6)
hI/(I)i 23.6 (5.7)
Rr.i.m. 0.132 (0.595)
Overall B factor from Wilson plot (A˚2) 52.38
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occupying the1 subsite is slightly skewed compared with the
regular chair conformation in both chain A and chain B. This
is observed both by visual inspection in Coot and as seen in the
coordinates given by Privateer. This is likely to be owing to the
enzyme forcing the substrate into a higher energy conforma-
tion or simply owing to the limitations of modelling at 2.7 A˚
resolution. However, it is important to note that additional
distortion would be needed in a complex with a substrate
spanning the 1/+1 subsites, since in the current product
complex the catalytic nucleophile does not reach the scissile
bond.
3.2. Subsite 2
This subsite is located between Trp86 and Gly308, where
Trp86 serves as an aromatic platform to stack with the galac-
tose unit. The O6 of galactose is hydrogen-bonded to N2 of
Asn304, while O2 is hydrogen-bonded to O2 of Asp88.
The structure of AaGal in complex with galactobiose at
subsites1 and2 is the ﬁrst structure of a fungal galactanase
in complex with a product. The ability of AaGal to bind
galactobiose at subsites 1 and 2 (Fig. 2) ﬁts together well
with the observed degradation (Ryttersgaard et al., 2004) and
transglycosidation (Torpenholt et al., 2011) patterns of AaGal.
AaGal has been shown to degrade galactotriose and galacto-
tetraose completely to galactose and galactobiose and to
produce galactose, galactobiose and 2-nitrophenol from the
hydrolysis of 2-nitrophenyl-1,4--d-galactopyranoside at high
concentrations, where galactobiose is thought to be a product
of transglycosidation (Torpenholt et al., 2011). In the structure
AaGal binds galactobiose nonproductively in subsites 1 and
2, presumably as a result of the high concentrations used for
soaking, but the fact that galactose is observed at the 1
subsite, which is rarely occupied in product complexes of
glycoside hydrolases, indicates a relatively high afﬁnity at
this subsite which makes transglycosidation with the small
chromogenic substrate possible. In contrast, the previously
research communications
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Figure 1
Galactobiose binding site in chain A of AaGal. (a) Overview of the enzyme with galactobiose. The galactobiose and glycosylation are shown in stick
representation (with yellow and green C atoms, respectively). Ca2+ ions are depicted as blue spheres and the polypeptide chain is shown as a grey ribbon.
The N-terminus and C-terminus are labelled and are coloured cyan and red, respectively. (b) The difference map before modelling of galactobiose
(Fobs  Fcalc map contoured at the 3.0 level). (c) Electron density for galactobiose (weighted 2Fobs  Fcalc map contoured at the 1.0 level).
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determined structure (PDB entry 2ccr; Ryttersgaard et al.,
2004) of BlGal, a bacterial galactanase, in complex with
galactobiose and galactotriose showed no binding at subsite
1, which ﬁts well with the inability of BlGal to degrade
(Ryttersgaard et al., 2004) or transglycosidate (Torpenholt et
al., 2011) small substrates. The amino-acid residues Asn135,
Trp297 and Tyr215 constructing subsite 1, Trp86 and Asp88
constructing subsite 2 and the two catalytic glutamates
Glu136 and Glu246 are conserved in AaGal and BlGal.
Asn304, Leu307 and Gly308 are observed in AaGal and
constitute a turn. Leu307 and Asn304 are hydrogen bonded to
the O6 hydroxyl group of galactose in subsites 1 and 2,
respectively. This turn is not observed in BlGal, as the corre-
sponding residues in BlGal are part of an extra-long loop 8
containing subsites 3 and 4. BlGal has an additional lysine
(Lys120) that interacts with the O3 hydroxyl group of galac-
tose at subsite 2 but lacks an appropriate residue corre-
sponding to Tyr218 in AaGal for interaction with the O6
hydroxyl group of galactose in subsite 1 (Fig. 2). Alignment
of the available galactanase sequences has shown that Lys120
is conserved in most bacterial galactanases and that Asn135,
Trp297, Trp86, Asp88, Leu307, Gly308 and Asn304 are
conserved in fungal galactanases. Tyr218 is conserved in many
fungal galactanases and is a tryptophan in BlGal.
Some disorder is observed in the structure, mainly at
calcium-bridging carboxylate side chains, which could indicate
that numerous possibilities are available for rearranging the
water molecules around the bridges. Trp163 also seems to be
disordered and is most likely to adopt several conformations,
but owing to the relatively low resolution it has not been
possible to model it satisfactorily.
In recent years, galactanases have increasingly been char-
acterized as part of the galactan/galactose-utilization systems
of human gut bacteria (see, for example, Hinz et al., 2005; van
Bueren et al., 2017; Bo¨ger et al., 2019), the pivotal role of which
in human health is increasingly being recognized. Simulta-
neously, galactose-containing oligosaccharides are increas-
ingly being recognized as prebiotic agents that are able to
promote the ‘good’ bacteria in the gut. The present structure
provides additional information to the knowledge on ligand
binding in fungal galactanases in particular, but additionally it
shows an occupied 1 subsite, which is relatively rare for
glycoside hydrolases in general and has not previously been
observed for GH53 galactanases. Structural knowledge of the
1 subsite is important as a starting point for theoretical
calculations on the catalytic function, particularly the trans-
glycosidation reaction, and also for protein engineering with a
view to changing the product and substrate preferences of
enzymes used in the production of oligosaccharides.
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